To include your compound in the COVID-19 Resource Center, submit it here.

Propofol IDD-D 2%: Phase II

In a double-blind U.S. Phase II trial in 78 females undergoing laparoscopic gynecological

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE